PDCD1LG2 and neoplasm: ATRX mutations also influence immune pathways by modulating the tumor microenvironment, promoting immune cell infiltration while upregulating immune checkpoint proteins like PD-L1 and PD-L2, which may facilitate immune escape58,76.